sars-cov-2

Covid-19 Considerations

As we try to find a new normal living with Covid-19 it is important to stay vigilant with regard to risks. The more shops, establishments, events and facilities we visit the higher our risk of exposure to viral spread; particularly if in an enclosed space with asymptomatic carriers. Vaccination helps to[…]

Read More »

Testing positive for Covid-19 on holiday in Gibraltar

If you test positive for Covid-19 on entry to Gibraltar or during your stay, the Contact Tracing team (CTB) will contact you. You will be advised on isolation and given guidance to prevent further spread. It is likely: You will be unable to travel within a 10-day period (this may[…]

Read More »

Long Covid

Emerging evidence indicates that there are several short and long-term health effects associated with COVID-19. As the pandemic unfolds, studies indicate that there are many ways infection with Covid-19 can affect someone’s health; and many organs besides the lungs are affected. How long it takes to recover from coronavirus is[…]

Read More »

Covid-19 Vaccination – Registering your interest

Please click the relevant link below to complete the form to register your interest for Covid-19 vaccination. General registration form University Students 65 – 70 years of age Over 70 years of age (You can also call 200 66966 to arrange) CAT2 individuals Note, if you have previously submitted your[…]

Read More »

Weekly Covid Vaccine Statistics

This data represents the number of vaccine doses given to people in Gibraltar, not the number of people fully vaccinated.   To compare local data with that of other countries, see World Data HERE.

Read More »

Yr2021 – Government Press Releases related to COVID-19

Scroll down or click on the relevant month: January February March April May June June June 10th – 450/2021 – Updates to COVID-19 testing and self-isolation requirements for travel to Gibraltar  June 10th – 449/2021 – Hillsides visits suspended temporarily as a precaution June 4th – 440/2021 – First case of[…]

Read More »

Pfizer-BioNTech COVID-19 Vaccine

As of  November 9th 2020, Pfizer and BioNTech industries have announced the production of a vaccine that has passed the final ‘phase III’ of human round testing. Based on evidence from clinical trials, the Pfizer-BioNTech vaccine was 95% effective at preventing laboratory-confirmed COVID-19 illness in people without evidence of previous infection.[…]

Read More »

Oxford/ AstraZeneca Vaccine

As of 30th December 2020 the UK Government have accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s Covid-19 vaccine for use. This follows rigorous clinical trials and a thorough analysis of the data by experts at the MHRA, which has concluded that[…]

Read More »
1 2 3